[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581281":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":34,"responsibleParty":47,"collaborators":49,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":18,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":18,"maxAge":60,"enrollmentInfo":61,"targetDuration":18,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":74,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Universidade do Porto","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Early follow up by the palliative care team","ACTIVE_COMPARATOR","Early follow up by the palliative care team, that is, from diagnosis",[13],"Other: Early palliative care integration",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard of care: conventional treatment","NO_INTERVENTION","Conventional treatment by the Hematology team where this referral is made only in specific cases in which hematologists understand that this need exists.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Early palliative care integration","Early follow up by the palliative care team, from diagnosis",[9],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Rita Damas, MD","CONTACT","+351 917312684","ritaisabeldamas@gmail.com",{"name":31,"role":27,"phone":32,"phoneExt":18,"email":33},"Janete Santos, PhD","+351 225 513 600","investigaclinica@med.up.pt",[35],{"facility":36,"status":18,"city":37,"state":18,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":18},"Centro Hospitalar e Universitário de São João","Porto","4200-319","Portugal","PT",{"type":42,"coordinates":43},"Point",[44,45],-8.61097,41.1485,{"lat":45,"lon":44},{"type":48,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[50],{"name":51,"class":6},"Centro Hospitalar De São João, E.P.E.","100581281","effectiveness-of-early-intervention-in-palliative-care-for-acute-myeloid-leukemia-patients-comparing-to-standard-of-care-100581281",false,"NCT06848270","Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care","Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care: a Randomized Pragmatic Clinical Trial, 1:1 Ratio, Parallel Group and Superiority Study","Inclusion Criteria:\n\n* Capable of making decisions\n* Diagnosed with acute myeloid leukemia\n* Aged 70 years or less\n* Treated or referred for treatment at the Hematology department of Centro Hospitalar e Universitário de São João.\n\nExclusion Criteria:\n\n* All patients referred for \"best supportive care\", that is, for supportive care including treatment with cytoreductive intent.","ALL","70 Years",{"count":62,"type":63},50,"ESTIMATED","INTERVENTIONAL",[66],"NA","Hemato-oncology patients undergoing intensive chemotherapy treatments experience different types of symptoms during and after treatments, which are often refractory to the established therapy. Physical symptoms such as pain, dyspnea, mucositis, insomnia, loss of appetite, constipation and diarrhea, among others, have a huge impact on quality of life, temporarily until symptomatic control, but also permanently with the development of anxiety, depression, long-term fatigue and post-traumatic stress. As recommended by ASCO (American Society of Clinical Oncology), the palliative approach to oncological diseases must be as early as possible and be part of the \"standard of care\". However, the lack of concrete data on this topic in the last decade served as a barrier to the early integration of this same care for hemato-oncology patients in its various areas. Palliative care presupposes global, interdisciplinary action, carried out by specific teams that must act in situations of incurable or serious illness, in an advanced and progressive phase. The potential benefits can be countless and of significant importance, from the impact on quality of life, symptomatic control, reduction of anxiety and depression and even the promotion of informed and conscious choices at the end of life as well as the reduction of aggressive strategies. used at this stage of the disease.",[69,70],"Palliative Care","Acute Myeloid Leukaemia",[72,73],"Acute myeloid leukaemia","Palliative care","NOT_YET_RECRUITING","2025-02-21",{"date":77,"type":78},"2025-02-27","ACTUAL",{"date":80,"type":63},"2025-04-01",{"date":82,"type":63},"2026-08-01",{"name":5,"class":6},1]